Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Dehydrocholic acid

Dehydrocholic acid (Dehydrocholate) is an orally active hydrocholeretic agent. Dehydrocholic acid modulates Autophagy, reduces serum amylase and lipase levels. Dehydrocholic acid has the effects of promoting choleretic function, protecting the liver, reducing pancreatic damage, and regulating cholesterol metabolism. Dehydrocholic acid can be used in the study of acute biliary pancreatitis and obstructive jaundice[1][2][3][4][5].

Product Specifications

CAS Number

[81-23-2]

Product Name Alternative

Dehydrocholate

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Amylases; Autophagy; Lipase

Type

Reference compound

Related Pathways

Autophagy; Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/Dehydrocholic-acid.html

Purity

99.92

Solubility

DMSO : 25 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL

Smiles

C[C@H](CCC(O)=O)[C@H]([C@]12C)CC[C@@]1([H])[C@]3([H])C(C[C@]4([H])CC(CC[C@]4(C)[C@@]3([H])CC2=O)=O)=O

Molecular Formula

C24H34O5

Molecular Weight

402.52

Precautions

H302, H315, H319, H335

References & Citations

[1]Zhang X, et al. Dehydrocholic Acid Ameliorates Sodium Taurocholate-Induced Acute Biliary Pancreatitis in Mice. Biol Pharm Bull. 2020;43 (6) :985-993.|[2]Yousef IM, et al. Influence of dehydrocholic acid on the secretion of bile acids and biliary lipids in rats. Digestion. 1990;45 (1) :40-51.|[3]Ratan J, et al. A controlled trial of choleretic and hepatoprotective actions of Livzon and dehydrocholic acid in a model of obstructive jaundice in albino rats. Tohoku J Exp Med. 1997 Jan;181 (1) :161-6.|[4]UCHIDA K, et al. EFFECTS OF SODIUM URSODEOXYCHOLATE, HYODEOXY-CHOLATE AND DEHYDROCHOLATE ON CHOLESTEROL AND BILE ACID METABOLISM IN RATS. Journal of Pharmacobio-Dynamics, 1983, 6 (5) : 346-357.|[5]Magos L, et al. The effect of phenobarbital and sodium dehydrocholate on the biliary excretion of methylmercury in the rat. Toxicology and Applied Pharmacology, 1974, 30 (1) : 1-6.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

ApoC-III (APOC3, Apolipoprotein C-III, Apo-CIII, Apolipoprotein C3)
306415-01 50 µg

ApoC-III (APOC3, Apolipoprotein C-III, Apo-CIII, Apolipoprotein C3)

Ask
View Details
ApoC-III (APOC3, Apolipoprotein C-III, Apo-CIII, Apolipoprotein C3)
306415-02 100 µg

ApoC-III (APOC3, Apolipoprotein C-III, Apo-CIII, Apolipoprotein C3)

Ask
View Details
CPNE1 (Copine I, Copine-1, COPN1, CPN1, MGC1142) (APC)
137898-APC 100 µL

CPNE1 (Copine I, Copine-1, COPN1, CPN1, MGC1142) (APC)

Ask
View Details
Bmpr1a, ID (Bmpr1a, Acvrlk3, Bmpr, Bone morphogenetic protein receptor type-1A, Activin receptor-like kinase 3, BMP-2/BMP-4 receptor, Serine/threonine-protein kinase receptor R5, CD292) (APC) discontinued
032546-APC 200 µL

Bmpr1a, ID (Bmpr1a, Acvrlk3, Bmpr, Bone morphogenetic protein receptor type-1A, Activin receptor-like kinase 3, BMP-2/BMP-4 receptor, Serine/threonine-protein kinase receptor R5, CD292) (APC) discontinued

Ask
View Details
TSC22D1 CRISPRa sgRNA lentivector (set of three targets)(Rat)
48545126 3x 1.0µg DNA

TSC22D1 CRISPRa sgRNA lentivector (set of three targets)(Rat)

Ask
View Details
AZ084
MBS3843600-01 1 mg

AZ084

Ask
View Details